Microbial Drug Resistance

Scope & Guideline

Illuminating the Path to Effective Antimicrobial Strategies

Introduction

Welcome to the Microbial Drug Resistance information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Microbial Drug Resistance, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1076-6294
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationMICROB DRUG RESIST / Microb. Drug Resist.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The journal 'Microbial Drug Resistance' focuses on the multifaceted aspects of drug resistance in microorganisms, particularly how these resistances affect treatment options and public health. The journal aims to disseminate research that enhances the understanding of microbial resistance mechanisms, epidemiology, and the development of novel therapeutic strategies.
  1. Mechanisms of Drug Resistance:
    Research articles explore the genetic, biochemical, and physiological mechanisms by which bacteria and fungi develop resistance to antimicrobial agents, including beta-lactams, macrolides, and newer antibiotics.
  2. Clinical Implications of Resistance:
    The journal emphasizes studies that investigate the clinical consequences of antimicrobial resistance, including treatment failures, infection outcomes, and the implications for public health.
  3. Surveillance and Epidemiology:
    Publications include epidemiological studies that track the prevalence and distribution of resistance genes in various environments, including hospitals, communities, and animal populations.
  4. Novel Therapeutic Approaches:
    Research on new antimicrobial agents, combination therapies, and alternative treatment strategies is a key focus, showcasing efforts to combat resistance in clinical settings.
  5. Environmental and One Health Perspectives:
    The journal also covers studies that assess the environmental impact of resistant pathogens and the interconnectedness of human, animal, and environmental health in the context of antimicrobial resistance.
The journal has identified several emerging themes that reflect the current challenges and advancements in the field of microbial drug resistance. These trends indicate a shift towards more complex and integrative approaches to understanding and combating resistance.
  1. Characterization of Resistance Genes and Mobile Elements:
    There is a growing emphasis on the characterization of resistance genes, particularly those located on mobile genetic elements such as plasmids, which facilitate the spread of resistance across different bacterial species.
  2. Impact of COVID-19 on Resistance Trends:
    Research examining how the COVID-19 pandemic has influenced antimicrobial resistance patterns, treatment practices, and infection control measures has gained significant attention.
  3. Use of Advanced Genomic Techniques:
    The application of whole-genome sequencing and other genomic techniques to analyze resistance mechanisms and track outbreaks is becoming increasingly prevalent in published studies.
  4. Environmental Resistance Dynamics:
    Emerging research focuses on the dynamics of antimicrobial resistance in environmental contexts, including wastewater, agricultural settings, and wildlife, highlighting the importance of a One Health approach.
  5. Innovative Therapeutic Strategies:
    There is a rising interest in exploring novel therapeutic strategies, including the use of bacteriophages, antimicrobial peptides, and combination therapies, to overcome drug resistance.

Declining or Waning

While the journal continues to focus on critical themes related to microbial drug resistance, certain areas of research have seen a decline in prominence over the recent publication years. These waning themes may reflect shifts in research priorities or advancements in understanding that have made some topics less central to ongoing discourse.
  1. Antibiotic Stewardship in Specific Settings:
    Although antibiotic stewardship remains important, there has been a noticeable decline in studies focusing solely on stewardship practices within specific healthcare settings, as more comprehensive and integrated approaches are being adopted.
  2. Basic Laboratory Techniques for Resistance Detection:
    Research centered around traditional laboratory methods for detecting resistance, such as disk diffusion or standard broth microdilution, appears to be less frequent, as newer molecular and rapid testing methods gain traction.
  3. Single-Pathogen Studies:
    The trend has shifted towards multi-pathogen studies and broader environmental assessments, leading to a decrease in publications focusing exclusively on single-pathogen resistance profiles.
  4. Global Surveys of Resistance Patterns:
    While still relevant, the frequency of global surveys of resistance patterns has diminished, possibly due to the increasing focus on localized studies that address specific regional challenges.

Similar Journals

Expert Review of Anti-Infective Therapy

Advancing the Fight Against Infectious Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-7210Frequency: 12 issues/year

Expert Review of Anti-Infective Therapy, published by Taylor & Francis Ltd, is a leading journal in the field of infectious diseases, microbiology, and virology, boasting an impressive impact factor and ranking in the Q1 category across multiple disciplines. With an ISSN of 1478-7210 and E-ISSN 1744-8336, this journal has become a vital resource for researchers, professionals, and students aiming to advance their understanding of anti-infective therapies. Since its inception in 2003, the journal has provided critical insights, evidence-based reviews, and forward-thinking perspectives that contribute significantly to the ongoing efforts in combating infectious diseases. As of 2023, it ranks #36 out of 344 in Medicine/Infectious Diseases and maintains high percentiles in various other categories, reflecting its influence and reach within the scientific community. Although not an Open Access journal, its rich content is delivered through various academic libraries, sustaining its commitment to disseminating knowledge in the face of global health challenges. For those committed to innovation in the field, the Expert Review of Anti-Infective Therapy offers a platform that blends thorough research with practical applications, making significant strides in the fight against infectious pathogens.

INDIAN JOURNAL OF MICROBIOLOGY

Innovating Solutions Through Microbial Research
Publisher: SPRINGERISSN: 0046-8991Frequency: 4 issues/year

INDIAN JOURNAL OF MICROBIOLOGY, published by Springer, serves as a vital platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0046-8991 and an E-ISSN of 0973-7715, this esteemed journal invites contributions that span various disciplines within microbiology, encompassing both fundamental studies and applied research that can impact health, environment, and industry. Recognized in the Q3 category in Microbiology for 2023, and ranking #80 out of 182 in Scopus’ Microbiology category, it reflects its commitment to quality and significance in the academic community. Authors and researchers benefit from the journal's comprehensive review process, which enhances the visibility and reach of their work. While no open access options are currently offered, the INDIAN JOURNAL OF MICROBIOLOGY remains a premier choice for those aiming to contribute to the ongoing dialogue in microbiological studies, ensuring that knowledge continues to evolve and thrive.

CRITICAL REVIEWS IN MICROBIOLOGY

Synthesizing Expertise for a Deeper Understanding
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-841XFrequency: 4 issues/year

CRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.

Mediterranean Journal of Infection Microbes and Antimicrobials

Fostering global collaboration on microbial challenges.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

MIKROBIYOLOJI BULTENI

Illuminating the Pathways of Microbial Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Lancet Microbe

Elevating the Standards of Microbial Science
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Transforming Food Safety with Cutting-edge Science
Publisher: ELSEVIERISSN: 0168-1605Frequency: 24 issues/year

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY is a leading journal in the field of food safety and microbiology, published by Elsevier. With an impressive impact factor and a distinguished position, it ranks in the top quartile for both Food Science and Medicine, as well as holding a strong presence in Microbiology and Safety, Risk, Reliability, and Quality categories. The journal provides a vital platform for researchers, professionals, and students to disseminate and discuss innovative research findings and applications that address the complexities of food microbiology. Operating from its headquarters in the Netherlands, this journal not only facilitates access to high-quality scholarly articles but also encourages the development of interdisciplinary approaches to tackle current challenges in food safety and public health. Since its inception in 1984, the journal has continually evolved, ensuring that it remains at the forefront of scientific inquiry, making it a crucial resource for anyone engaged in the food sciences.

BMC MICROBIOLOGY

Transforming health and environment through microbiological excellence.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.

Revista Espanola de Quimioterapia

Bridging Research and Practice in Medicinal Chemistry
Publisher: SOCIEDAD ESPANOLA QUIMIOTERAPIAISSN: 0214-3429Frequency: 6 issues/year

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

JOURNAL OF CHEMOTHERAPY

Exploring Breakthroughs in Infectious Disease Treatment
Publisher: TAYLOR & FRANCIS LTDISSN: 1120-009XFrequency: 6 issues/year

Journal of Chemotherapy is a distinguished peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the dynamic fields of infectious diseases, oncology, and pharmacology. With its ISSN 1120-009X and E-ISSN 1973-9478, this journal has been at the forefront of chemotherapy research since its inception in 1989 and continues to play a vital role in advancing medical science through rigorous studies and reviews. It currently holds a respectable position in various Scopus categories, ranked Q3 in several important disciplines, reflecting its commitment to providing quality research. Although it operates under a subscription model, Journal of Chemotherapy remains a crucial resource for practitioners and academics alike, facilitating knowledge exchange and innovation in the treatment of diseases through chemotherapy. With access to the latest findings and therapeutic advancements, this journal is a must-read for researchers, medical professionals, and students seeking to enhance their understanding of emerging trends in chemotherapy.